Outcome Measure
Health Anxiety Inventory-18
What it measures?
- The items of the HAI-18 are intended to evaluate health anxiety regardless of physical health status. These items measure concerns about health, awareness of bodily sensations or changes, and the feared consequences of having an illness.
- The HAI-18 (also known as the SHAI) is an 18-item abbreviated version of the original 64-item Health Anxiety Inventory (HAI; Salkovskis et al. 2002).
- To develop the SHAI, Salkovskis et al. selected the 14 items from the HAI that had the highest item-total correlation in a sample of health care patients. They then added four additional items based on theoretical considerations. A two-factor solution best represents the SHAI items in both nonclinical and clinical samples (Abramowitz et al. 2007b; Wheaton et al. 2010).
- Many earlier studies, including a systematic review have supported a two-factor structure, consisting of Illness Likelihood (items 1-14; i.e: fear of developing a serious health condition or illness) and Negative Consequences (sometimes referred to as Illness Severity; items 1-15; i.e. affective concerns about the negative ramifications of acquiring an illness or health condition; Alberts et al., 2010; Fergus & Valentiner, 2011; Wheaton et al., 2010). More recent research has found only weak support for the proposed subscales, arguing that HAI-18 items tap a single underlying construct (Axelsson et al., 2023). These authors found that “worry about health and the fear of serious illness was at the core of the trait health anxiety constructel” (Axelsson et al., 2010, p. 11).
Who is it for?
Adults aged 18 years +
Instrument Quality
- The shorter version of the health anxiety measure has been widely used in various settings and has demonstrated comparable performance to other well-established health anxiety assessment tools (Axelsson et al., 2023).
Structure
- 18 items
- 4-point Likert scale
- For each item, respondents must choose from several statements assessing the extent of health- and somatic-related concerns during the past 6 months (e.g. “I occasionally worry about my health”).
- Each item is scored from 0 to 3 points, with less healthy responses yielding a higher item score.
Scoring instructions
- Sum all item responses to derive the full-scale HAI-18 score.
Subscale | Item number |
---|---|
Negative Consequences (HAI-18) |
15,16,17,18 |
Illness Likelihood (HAI-18) |
1,2,3,4,5,6,7,8,9,10,11,12,13,14 |
Full-scale (HAI-18) |
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 |
Score Interpretation
What higher scores mean?
- Higher scores on the HAI-18 indicate more severe health anxiety. Research by Axelsson and colleagues (2023) supports the following severity ranges: Normative range (0-25): Indicates non-clinical levels of health anxiety according to other established health anxiety measures. In a sample of healthy volunteers (N = 88) the mean HAI-18 score was 8.1 (SD = 4.5). Mild pathological health anxiety (26-32): Indicates pathological health anxiety at a mild level, which may require some clinical attention. For comparison with other established measures of health anxiety, a cutoff of 26 roughly corresponds to a score of 22 on the HAI-14, 82–83 on the HAI-64, 52–53 on the IAS, and 7–8 on the WI-14. Moderate pathological health anxiety (33-39): Indicates symptoms of health anxiety that are not quite within severe and clinical range—but not mild either. The ‘moderate’ label is not explicitly referenced by Axelsson and colleagues (2023), but is inferred through their comparison of HAI-18 severity ranges with those of other health anxiety assessment instruments. In patients diagnosed with Somatic Symptom Disorder or Illness Anxiety Disorder (N = 335), based on the DSM-5 criteria, the average HAI-19 score was 35.5 (SD = 6.2; Axelsson et al., 2023). Clinical (severe) pathological health anxiety (40-53): Indicates ‘substantial’ health anxiety symptoms that are likely to be within a clinical range. The patient is likely to be experiencing significant distress. Maximum (54): A score of 54 on the HAI-18 is the highest possible score, reflecting severe health anxiety.
How to assess symptom severity & change?
Description | Score Range | |
---|---|---|
Below normative mean | 0 | |
Normative mean | 2.67 | |
1 SD above normative mean | 4.85 | |
2 SD above normative mean | 7.03 | |
Hypochondriasis mean | 7.8 | |
1 SD above Hypochondriasis mean | 10.6 | |
Maximum | 12 |
Description | Score Range | |
---|---|---|
Below normative mean | 0 | |
Normative mean | 9.8 | |
1 SD above normative mean | 14.9 | |
2 SD above normative mean | 20 | |
Hypochondriasis mean | 30.1 | |
1 SD above Hypochondriasis mean | 35.6 | |
Maximum | 42 |
Severity ranges
* Higher scores on the HAI-18 indicate more severe health anxiety. * Research by Axelsson and colleagues (2023) supports the following severity ranges: * Normative range (0-25): Indicates non-clinical levels of health anxiety according to other established health anxiety measures. In a sample of healthy volunteers (N = 88) the mean HAI-18 score was 8.1 (SD = 4.5). * Mild pathological health anxiety (26-32): Indicates pathological health anxiety at a mild level, which may require some clinical attention. For comparison with other established measures of health anxiety, a cutoff of 26 roughly corresponds to a score of 22 on the HAI-14, 82–83 on the HAI-64, 52–53 on the IAS, and 7–8 on the WI-14. * Moderate pathological health anxiety (33-39): Indicates symptoms of health anxiety that are not quite within severe and clinical range—but not mild either. The ‘moderate’ label is not explicitly referenced by Axelsson and colleagues (2023), but is inferred through their comparison of HAI-18 severity ranges with those of other health anxiety assessment instruments. In patients diagnosed with Somatic Symptom Disorder or Illness Anxiety Disorder, based on the DSM-5 criteria, the average HAI-19 score was 35.5 (SD = 6.2; Axelsson et al., 2023). * Clinical (severe) pathological health anxiety (40-53): Indicates ‘substantial’ health anxiety symptoms that are likely to be within a clinical range. The patient is likely to be experiencing significant distress. * Maximum (54): A score of 54 on the HAI-18 is the highest possible score, reflecting severe health anxiety.
Reliable change and clinically significant improvement
Wampold et al. (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 30.1 | The research sample included twenty-four English participants diagnosed with hypochondriasis (Salkovskis et al., 2002). |
Normative | 9.8 | * The research sample comprised 503 undergraduate students enrolled in an introductory psychology course at a university in the Midwest (Fergus & Valentiner, 2011). * The reported mean and standard deviation are comparable to the values obtained by Salkovskis and colleagues (2002) in their validation study of the HAI-18 (M = 9.6; SD = 4.5). |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 5.5 | The research sample included twenty-four English participants diagnosed with hypochondriasis (Salkovskis et al., 2002). |
Normative | 5.1 | * The research sample comprised 503 undergraduate students enrolled in an introductory psychology course at a university in the Midwest (Fergus & Valentiner, 2011). * The reported mean and standard deviation are comparable to the values obtained by Salkovskis and colleagues (2002) in their validation study of the HAI-18 (M = 9.6; SD = 4.5). |
Reliability
Value | Comments |
---|---|
0.86 | The provided value is Cronbach’s alpha, as reported by Wheaton and colleagues (2010), based on a large sample of undergraduate students (N = 636). |
Description | Score Range | |
---|---|---|
Normative | 0 | |
Mild pathological health anxiety | 26 | |
Illness anxiety disorder/somatic symptom disorder | >=26 | Provisional Diagnosis |
Moderate pathological health anxiety | 33 | |
Clinical (severe) pathological health anxiety | 40 | |
Maximum | 54 |
Severity ranges
* Higher scores on the HAI-18 indicate more severe health anxiety. * Research by Axelsson and colleagues (2023) supports the following severity ranges: * Normative range (0-25): Indicates non-clinical levels of health anxiety according to other established health anxiety measures. In a sample of healthy volunteers (N = 88) the mean HAI-18 score was 8.1 (SD = 4.5). * Mild pathological health anxiety (26-32): Indicates pathological health anxiety at a mild level, which may require some clinical attention. For comparison with other established measures of health anxiety, a cutoff of 26 roughly corresponds to a score of 22 on the HAI-14, 82–83 on the HAI-64, 52–53 on the IAS, and 7–8 on the WI-14. * Moderate pathological health anxiety (33-39): Indicates symptoms of health anxiety that are not quite within severe and clinical range—but not mild either. The ‘moderate’ label is not explicitly referenced by Axelsson and colleagues (2023), but is inferred through their comparison of HAI-18 severity ranges with those of other health anxiety assessment instruments. In patients diagnosed with Somatic Symptom Disorder or Illness Anxiety Disorder, based on the DSM-5 criteria, the average HAI-19 score was 35.5 (SD = 6.2; Axelsson et al., 2023). * Clinical (severe) pathological health anxiety (40-53): Indicates ‘substantial’ health anxiety symptoms that are likely to be within a clinical range. The patient is likely to be experiencing significant distress. * Maximum (54): A score of 54 on the HAI-18 is the highest possible score, reflecting severe health anxiety.
Provisional diagnosis
* According to Axelsson and colleagues (2023), a HAI-18 score of 26 indicates the likely presence of DSM-5 Illness Anxiety Disorder or Somatic Symptom Disorder. * A mean score of 35.5 was obtained using a sample of patients with fear of or fixation on serious illness, who fully met the criteria for a primary diagnosis of somatic symptom disorder or illness anxiety disorder based on DSM-5. These diagnoses were made by a clinical psychologist using the Health Preoccupation Diagnostic Interview and the Mini-International Neuropsychiatric Interview (Axelsson et al., 2023). * For comparison with other established measures of health anxiety, a cutoff of 26 roughly corresponds to a score of 22 on the HAI-14, 82–83 on the HAI-64, 52–53 on the IAS, and 7–8 on the WI-14.
Reliable change and clinically significant improvement
Wampold et al. (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Sample | Mean | Comments |
---|---|---|
Clinical | 35.5 | In a clinical trial study consisting of 335 participants with pathological health anxiety, mean sum score of HAI-18 was 35.5 and SD=6.2 (Axelsson et al., 2023). |
Normative | 8.1 | * In a sample of health volunteers (N = 88), Axelsson and colleagues (2023) reported a mean HAI-18 score of 8.1 (SD = 4.5) * In other research, the full-scale mean HAI-18 score was reported to be 10.79 (SD = 6.38) using on a large sample (N= 467) of medically healthy undergraduate students from introductory psychology courses at a university in the Midwestern United States (Abramowitz et al., 2007) |
Standard Deviation
Sample | Mean | Comments |
---|---|---|
Clinical | 6.2 | In a clinical trial study consisting of 335 participants with pathological health anxiety, mean sum score of HAI-18 was 35.5 and SD=6.2 (Axelsson et al., 2023). |
Normative | 4.5 | * In a sample of health volunteers (N = 88), Axelsson and colleagues (2023) reported a mean HAI-18 score of 8.1 (SD = 4.5) * In other research, the full-scale mean HAI-18 score was reported to be 10.79 (SD = 6.38) using on a large sample (N= 467) of medically healthy undergraduate students from introductory psychology courses at a university in the Midwestern United States (Abramowitz et al., 2007) |
Reliability
Value | Comments |
---|---|
0.96 | * A systematic review (Alberts et al., 2013) reported Cronbach’s alpha coefficients for the HAI-18 ranging from 0.74 to 0.96 across various samples (Abramowitz et al., 2007; Ramchandani et al., 2011; Wheaton et al., 2011; Fergus & Valentiner, 2011a, 2011b). * We could not identify a study evaluating test-retest reliability using the HAI-18. However, test-retest reliability of 0.9 was reported by Salkovskis and colleagues (2002) in their seminal paper on the development of the original 64-item HAI. |
Instrument developers
- Salkovskis, P. M., Rimes, K. A., Warwick, H. M. C., & Clark, D. M. (2002). The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychological Medicine, 32(5), 843 853. https://doi.org/10.1017/S0033291702005822.
Refrences
* Axelsson, E., Österman, S., & Hedman-Lagerlöf, E. (2023). Joint factor analysis and approximate equipercentile linking of common trait health anxiety measures: a cross-sectional study of the 14-, 18-and 64-item health anxiety inventory, the illness attitude scale, and the 14-item Whiteley Index. BMC psychiatry, 23(1), 658. * Fergus, T. A., & Valentiner, D. P. (2011). The short health anxiety inventory and multidimensional inventory of hypochondriacal traits: A comparison of two self-report measures of health anxiety. Cognitive Therapy and research, 35, 566-574. * Salkovskis, P. M., Rimes, K. A., Warwick, H. M. C., & Clark, D. M. (2002). The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychological Medicine, 32(5), 843–853. https://doi.org/10.1017/S0033291702005822. * Warwick, H. M. & Salkovskis, P. M. (1990). Hypochondriasis. Behaviour Research and Therapy 28, 105–117. * Warwick, H. M., Clark, D. M., Cobb, A. M., & Salkovskis, P. M. (1996). A controlled trial of cognitive–behavioural treatment of hypochondriasis. The British Journal of Psychiatry, 169(2), 189-195. * Wheaton, M. G., Berman, N. C., Franklin, J. C., & Abramowitz, J. S. (2010). Health anxiety: Latent structure and associations with anxiety-related psychological processes in a student sample. Journal of Psychopathology and Behavioral Assessment, 32, 565-574.
Related Outcome Measures
CORE-10
Clinical Outcomes in Routine Evaluation 10
The Clinical Outcomes in Routine Evaluation 10 (CORE-10) is a 10-item assessment measure for common...
FFMQ
Five Facet Mindfulness Questionnaire
RAADS-R
Ritvo Autism Asperger Diagnostic Scale-Revised
The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R) is a 80-item self-report assessment me...
HAI-18
Health Anxiety Inventory-18
The items of the HAI-18 are intended to evaluate health anxiety regardless of physical health stat...
CESD-R
Center for Epidemiological Studies Depression Scale
The Center for Epidemiological Studies Depression Scale (CESD-R) is a self-report questionnaire des...
AQ-Child
Autism Spectrum Disorder in Children
The AQ-Child aims to assess traits of Autism Spectrum Disorder (ASD) in children with average intell...
AQ-Adolescent
Autism Spectrum Disorder in Adolescents
The AQ-Adol aims to assess traits of Autism Spectrum Disorder (ASD) in adolescents with average inte...
MDQ
Mood Disorder Questionnaire
The Mood Disorder Questionnaire (MDQ) was developed as a screening measure for bipolar disorder, us...
DUDIT
Drug Use Disorders Identification Test
The Drug Use Disorders Identification Test (DUDIT) is an 11-item self-report assessment measure whi...
ITQ
International Trauma Questionnaire
The ITQ is a self-report measure designed to assess the presence and functional impairment of postt...
IES-R
Impact of Event Scale-Revised
The Impact of Event Scale-Revised (IES-R) is a tool designed to gauge the presence and severity of s...
ACE-Q
The Adverse Childhood Experiences Questionnaire
The Adverse Childhood Experiences Questionnaire (ACE-Q) is a widely used tool for assessing childho...
MDRS-22
Male Depression Risk Scale
The Male Depression Risk Scale (MDRS) measures the risk of depression in men by assessing externali...
DES-II
Dissociative Experiences Scale-II
The DES-II is the most commonly used measure of dissociation. It measures various types of dissocia...
PSC-17
Pediatric Symptom Checklist-17
The PSC-17 is a screening tool designed to assess a child’s overall psychosocial functioning and i...
PCL-5
PTSD Checklist for DSM-5
The 20 symptoms of Post-Traumatic Stress Disorder, as outlined in the Diagnostic & Statistical Manua...
FAS
Fatigue Assessment Scale
The FAS full-scale assesses symptoms of physical and mental fatigue.
AQ
Autism Spectrum Quotient
The AQ aims to assess traits of Autism Spectrum Disorder (ASD) in adults and adolescents with averag...
PDSS-SR
Panic Disorder Severity Scale – Self-Report
The severity of Panic Disorder symptoms during the past week. Specifically, the instrument assesses...
SCAS-P
Spence Children’s Anxiety Scale – Parent
The SCAS-P measures anxiety symptoms in children in the general population through parent report. T...
PSEQ
Pain Self-Efficacy Questionnaire
The beliefs held by people experiencing chronic pain that they can carry out certain activities even...
PHQ-9
Patient Health Questionnaire 9-Item
Symptoms of Depression over the previous 2 weeks.
RIS
Regensburg Insomnia Scale
Psychological symptoms of insomnia assessing cognitive, emotional and behavioural aspects. The RIS m...
PSWQ
Penn State Worry Questionnaire
The PSWQ assesses pervasive and uncontrollable worry.
TSK-13
Tampa Scale of Kinesiophobia 13-Item
Kinesiophobia, defined as “an excessive, irrational, and debilitating fear of physical movement an...
GAD-7
Generalised Anxiety 7-Item
The symptoms of Generalized Anxiety Disorder, as outlined in the Diagnostic and Statistical Manual ...
CIA
Clinical Impairment Assessment Questionnaire
The severity of psychosocial impairment due to eating disorder pathology.
AUDIT
Alcohol Use Disorder Identification Test
The AUDIT identifies risky or harmful alcohol consumption, as well as alcohol dependence or abuse. ...
OCI-R
Obsessive-Compulsive Inventory – Revised
Symptom severity of Obsessive-Compulsive Disorder (OCD).The OCI-R contains 6 factors representing th...
AAI
Appearance Anxiety Inventory
Cognitive and behavioural symptoms of body image anxiety and body dysmorphic disorder (BDD). In part...
K10
Kessler Psychological Distress Scale
Non-specific psychological distress in the past 2 weeks.
SWLS
The Satisfaction With Life Scale
The Satisfaction With Life Scale (SWLS) examines the extent to which a person is satisfied with thei...
DASS-21
Depression Anxiety Stress Scales – 21-Item
Three self-report subscales assess the emotional states of depression, anxiety and stress.
CORE-OM
Clinical Outcomes in Routine Evaluation
The CORE-OM aims to capture the ‘core’ of client distress and provide a global index of distres...
BSL-23
Borderline Symptom List
The BSL-23 assesses 23 feelings and experiences that are typically reported by patients with Border...
ASRS
Adult ADHD Self-Report Scale
The ASRS aims to examine Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults consiste...
Severity ranges
* Higher scores on the HAI-18 indicate more severe health anxiety. * Research by Axelsson and colleagues (2023) supports the following severity ranges: * Normative range (0-25): Indicates non-clinical levels of health anxiety according to other established health anxiety measures. In a sample of healthy volunteers (N = 88) the mean HAI-18 score was 8.1 (SD = 4.5). * Mild pathological health anxiety (26-32): Indicates pathological health anxiety at a mild level, which may require some clinical attention. For comparison with other established measures of health anxiety, a cutoff of 26 roughly corresponds to a score of 22 on the HAI-14, 82–83 on the HAI-64, 52–53 on the IAS, and 7–8 on the WI-14. * Moderate pathological health anxiety (33-39): Indicates symptoms of health anxiety that are not quite within severe and clinical range—but not mild either. The ‘moderate’ label is not explicitly referenced by Axelsson and colleagues (2023), but is inferred through their comparison of HAI-18 severity ranges with those of other health anxiety assessment instruments. In patients diagnosed with Somatic Symptom Disorder or Illness Anxiety Disorder, based on the DSM-5 criteria, the average HAI-19 score was 35.5 (SD = 6.2; Axelsson et al., 2023). * Clinical (severe) pathological health anxiety (40-53): Indicates ‘substantial’ health anxiety symptoms that are likely to be within a clinical range. The patient is likely to be experiencing significant distress. * Maximum (54): A score of 54 on the HAI-18 is the highest possible score, reflecting severe health anxiety.
Reliable change and clinically significant improvement
Wampold et al. (2001) conducted a meta-analysis of psychotherapy outcome studies and noted that the average improvement was reflected in an effect size (ES) of .80. Because a change of 1 SD corresponds to an ES of 1.0, and .80 is considered to be a large ES, Wise (2004) concludes that a change of 1 SD is a defensible indicator of clinically significant change.
Mean
Standard Deviation
Reliability